西菱動力(300733.SZ):擬進行航空零部件(大型環形件)生產線(二期)技術改造並取得項目備案
格隆匯 9 月 28日丨西菱動力(300733.SZ)公佈,根據公司軍工及航空零部件業務發展戰略規劃,公司計劃進行航空零部件(大型環形件)生產線(二期)技術改造並於近日取得了成都市青羊區新經濟和科技局的項目備案。
項目單位:成都西菱動力科技股份有限公司;項目名稱:航空零部件(大型環形件)生產線(二期)技術改造項目;項目總投資:項目總投資額1.4263億元。主要建設內容及規模:新建航空結構件自動生成線2條;新建航空鈑金件生產線1條;新建航空環形件及大型軸類件生產線1條。項目達成後形成年產航空結構件1.5萬隻、航空鈑金件80萬隻、軸類件600件的年生產能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.